ContributorsPublishersAdvertisers

Frontline Targeted Therapy for Newly Diagnosed High-Risk CLL

onclive.com
 2022-01-17

Cover picture for the articleSusan O’Brien, MD: So now we have this high-risk patient. What are your thoughts in terms of what are you thinking about treatment and what are the important characteristics here that lead you to that? Is it the mutation status, the FISH [fluorescence in situ hybridization]? We did not hear about...

www.onclive.com

Comments / 0

Comments / 0